Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comprehensive Assessment of Indices of Apoptosis and Endothelial Dysfunction and Methods of Their Correction in Patients With Atherosclerosis of Peripheral Arteries

NCT04502849 is registered in ClinicalTrials.gov with Ryazan State Medical University as lead sponsor.

NCT NCT04502849
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04502849 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comprehensive Assessment of Indices of Apoptosis and Endothelial Dysfunction and Methods of Their Correction in Patients With Atherosclerosis of Peripheral Arteries
Lead sponsor
Ryazan State Medical University
Phase
Observational
Overall status
Completed
Start date
January 1, 2020
Completion date
November 1, 2023
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, endothelial dysfunction